Kobayashi Pharmaceutical Co., Ltd. (TYO: 4967)

Market Cap	421.72B
Revenue (ttm)	168.80B
Net Income (ttm)	10.18B
Shares Out	74.34M
EPS (ttm)	136.67
PE Ratio	41.51
Forward PE	27.63
Dividend	101.00 (1.75%)
Ex-Dividend Date	Dec 27, 2024

Volume	282,400
Average Volume	313,860
Open	5,739.00
Previous Close	5,763.00
Day's Range	5,673.00 - 5,811.00
52-Week Range	4,700.00 - 6,866.00
Beta	0.23
RSI	42.07
Earnings Date	Feb 7, 2025

About Kobayashi Pharmaceutical

Kobayashi Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the manufacture and sale of OTC pharmaceuticals, guasi-drugs, deodorizing air fresheners, and sanitary products in Japan and internationally. The company offers Ammeltz, an anti-inflammatory pain relief medicine; Dent, an effervescent denture cleaning agent; Ekitai Bluelet Okudake, a toilet bowl cleaner; Naicitol, a Chinese medicine; BreathCare, an oral breath freshener capsule; Netsusama sheet, a cooling gel sheet; and deodorizing air freshener, lens cleaner, coolin...

• Industry: Household & Personal Products
• Sector: Consumer Staples
• Founded: 1886
• Employees: 3,534
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 4967

Financial Performance

In 2023, Kobayashi Pharmaceutical's revenue was 173.46 billion, an increase of 4.33% compared to the previous year's 166.26 billion. Earnings were 20.34 billion, an increase of 1.58%.